BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12163933)

  • 1. Kenya says yes to generic ARVs but fails to win Global Fund cash.
    Njoroge J
    Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
    [No Abstract]   [Full Text] [Related]  

  • 2. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians say generic AIDS drugs don't threaten R&D.
    AIDS Policy Law; 2002 Mar; 17(6):4. PubMed ID: 12004757
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV/AIDS: Latin America & Caribbean. Brazil: ten years after.
    Cohen J
    Science; 2006 Jul; 313(5786):484-7. PubMed ID: 16873654
    [No Abstract]   [Full Text] [Related]  

  • 5. Generic HIV drugs will widen US treatment net.
    Maxmen A
    Nature; 2012 Aug; 488(7411):267. PubMed ID: 22895314
    [No Abstract]   [Full Text] [Related]  

  • 6. [The patent legislation in India fails the HIV/AIDS work].
    Holen Ø
    Tidsskr Nor Laegeforen; 2005 Oct; 125(19):2666-7. PubMed ID: 16215618
    [No Abstract]   [Full Text] [Related]  

  • 7. Access to essential medications for HIV/AIDS in South Africa.
    Andrews S
    S Afr Med J; 2001 May; 91(5):384-7. PubMed ID: 11455797
    [No Abstract]   [Full Text] [Related]  

  • 8. Is there a role for generic antiretroviral drugs in the United States?
    Wormser GP; Lappas T
    Expert Rev Anti Infect Ther; 2014 Aug; 12(8):897-9. PubMed ID: 24918192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 10. World CAB II. This time it's generic.
    Huff B
    GMHC Treat Issues; 2005; 19(3-4):10-5. PubMed ID: 16003845
    [No Abstract]   [Full Text] [Related]  

  • 11. TRIPS post-2005 and access to new antiretroviral treatments in southern countries: issues and challenges.
    Orsi F; D'Almeida C; Hasenclever L; Camara M; Tigre P; Coriat B
    AIDS; 2007 Oct; 21(15):1997-2003. PubMed ID: 17885289
    [No Abstract]   [Full Text] [Related]  

  • 12. Laboratory monitoring of HIV--after access to antiretroviral drugs, the next challenge for the developing world.
    Tucker T; Yeats J
    S Afr Med J; 2001 Aug; 91(8):615. PubMed ID: 11584766
    [No Abstract]   [Full Text] [Related]  

  • 13. Global AIDS trial denied patients as US balks at generic drug use.
    Check E
    Nature; 2004 Sep; 431(7008):493. PubMed ID: 15457219
    [No Abstract]   [Full Text] [Related]  

  • 14. India: New patent law may restrict access to HIV/AIDS treatments.
    Cruess G
    HIV AIDS Policy Law Rev; 2005 Aug; 10(2):28-30. PubMed ID: 16365971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. U.S. near accord with WTO over generic drug access.
    AIDS Policy Law; 2003 Sep; 18(17):1. PubMed ID: 14626953
    [No Abstract]   [Full Text] [Related]  

  • 16. Global fund decides to promote use of generic drugs.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2002 Dec; 7(2-3):58-9. PubMed ID: 14740604
    [No Abstract]   [Full Text] [Related]  

  • 17. International. Rights group: U.S. blocking access to generic AIDS drugs.
    AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
    [No Abstract]   [Full Text] [Related]  

  • 18. Policy shift. Bush's AIDS plan includes condom distribution, generic drugs.
    AIDS Policy Law; 2003 Feb; 18(3):5. PubMed ID: 12635615
    [No Abstract]   [Full Text] [Related]  

  • 19. The danger of in-kind drug donations to the Global Fund.
    Baker BK; Ombaka E
    Lancet; 2009 Apr; 373(9670):1218-21. PubMed ID: 18848353
    [No Abstract]   [Full Text] [Related]  

  • 20. $15 million for infrastructure but no AIDS drugs for Jamaica.
    GMHC Treat Issues; 2003 Mar; 17(3):9-10. PubMed ID: 12728859
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.